Management of Bleeding Patients with Elevated PT/INR

Immediate Reversal Strategy

The American College of Cardiology recommends administering prothrombin complex concentrate (PCC) at weight-based dosing: 25 units/kg for INR 2-3.9, 35 units/kg for INR 4-5.9, or 50 units/kg for INR >6, as first-line therapy for actively bleeding patients with INR >1.5, along with intravenous vitamin K (5-10 mg) 1, 2, 3
PCC is superior to fresh frozen plasma (FFP) because it provides rapid onset of action and complete correction of vitamin K-dependent clotting factors, whereas FFP fails to achieve hemostatic factor levels in most patients 1, 2

For warfarin-associated bleeding, prioritize PCC over FFP because clotting factor concentrates achieve complete INR correction in 97% of patients versus incomplete correction with FFP in all patients 1
In cases of massive hemorrhage, activate massive transfusion protocol immediately without waiting for laboratory confirmation, and administer blood products in 1:1:1 ratio (RBC:FFP:platelets) for trauma and obstetric hemorrhage, as this approach improves survival from exsanguination 2, 3
Target fibrinogen >1.5 g/L (>2 g/L in obstetric hemorrhage) using cryoprecipitate, as fibrinogen drops earliest in dilutional coagulopathy 2, 5, 6, 7
Maintain platelets ≥75 × 10⁹/L throughout resuscitation, as counts <50 × 10⁹/L strongly associate with microvascular bleeding 2, 3

Recognize that standard FFP dosing is often inadequate: 15 ml/kg provides only partial factor replacement, and larger volumes may be required in established coagulopathy 2
Thaw FFP rapidly using dry oven (10 min), microwave (2-3 min), or water bath (20 min); once thawed, use within 30 minutes if at room temperature 5, 6, 7
Obtain baseline labs immediately: PT/INR, aPTT, fibrinogen, platelet count, and blood bank sample, and repeat coagulation studies every 4 hours or after 1/3 blood volume replacement during massive hemorrhage 1, 2, 3